373 related articles for article (PubMed ID: 17557668)
1. [Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
Bergmans JP; Kemna EH; Janssen MC; Jacobs EM; Stalenhoef AF; Marx JJ; Swinkels DW
Ned Tijdschr Geneeskd; 2007 May; 151(20):1121-7. PubMed ID: 17557668
[TBL] [Abstract][Full Text] [Related]
2. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
Arnold J; Sangwaiya A; Bhatkal B; Arnold A
Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
[TBL] [Abstract][Full Text] [Related]
3. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
[TBL] [Abstract][Full Text] [Related]
4. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
Shukla P; Julka S; Bhatia E; Shah S; Nagral A; Aggarwal R
Natl Med J India; 2006; 19(1):20-3. PubMed ID: 16570681
[TBL] [Abstract][Full Text] [Related]
5. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.
Roetto A; Camaschella C
Best Pract Res Clin Haematol; 2005 Jun; 18(2):235-50. PubMed ID: 15737887
[TBL] [Abstract][Full Text] [Related]
6. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches.
Swinkels DW; Janssen MC; Bergmans J; Marx JJ
Clin Chem; 2006 Jun; 52(6):950-68. PubMed ID: 16627556
[TBL] [Abstract][Full Text] [Related]
7. The iron driven pathway of hepcidin synthesis.
Deugnier Y
Gastroenterol Clin Biol; 2010; 34(6-7):351-4. PubMed ID: 20537480
[TBL] [Abstract][Full Text] [Related]
8. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
9. Review article: the genetic basis of haemochromatosis.
Griffiths WJ
Aliment Pharmacol Ther; 2007 Aug; 26(3):331-42. PubMed ID: 17635368
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of body iron homeostasis by hepcidin].
Lipiński P; Starzyński RR
Postepy Hig Med Dosw (Online); 2004 Mar; 58():65-73. PubMed ID: 15069380
[TBL] [Abstract][Full Text] [Related]
11. Hereditary haemochromatosis.
Janssen MC; Swinkels DW
Best Pract Res Clin Gastroenterol; 2009; 23(2):171-83. PubMed ID: 19414144
[TBL] [Abstract][Full Text] [Related]
12. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
[TBL] [Abstract][Full Text] [Related]
13. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
[TBL] [Abstract][Full Text] [Related]
14. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
Flanagan JM; Peng H; Beutler E
Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
[TBL] [Abstract][Full Text] [Related]
15. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.
Nicolas G; Andrews NC; Kahn A; Vaulont S
Blood; 2004 Apr; 103(7):2841-3. PubMed ID: 14656876
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis: genetics and pathophysiology.
Beutler E
Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
[TBL] [Abstract][Full Text] [Related]
19. [HFE hemochromatosis: pathogenic and diagnostic approach].
Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
